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Received 29 October 2010; received in revised form 1 December 2010; accepted 6 December 2010; Available online 15 January 2011AbstractPatients with stenosed biologic pulmonary conduits require redo cardiac surgery to prevent severe right ventricular dysfunction. Following the
latest trends, the trans-catheter pulmonary stent-valve implantation represents a new fascinating alternative carrying a lower operative risk,
compared with the standard open-heart re-intervention. Traditionally, the pulmonary stent valve is positioned off pump, under fluoroscopic
control, and requires angiographies. However, alternative tools not requiring contrast injections for the intra-operative cardiac imaging have to
be also considered strongly. The usefulness of intravascular ultrasound for the positioning of aortic endoprosthesis has already been proven in
previous reports and, following the same principle, we have started to routinely implant balloon-expandable stent valves (Edwards SapienTM THV)
in stenosed pulmonary valve conduits using intravascular ultrasound for the stent-valve positioning without angiography. We describe the intra-
operative intravascular imaging technique with technical details.
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Stenosis is a complication following surgery for pulmonary
outflow trunk reconstruction with biological conduits, such as
homografts or bovine jugular veins (ContegraW, Medtronic,
Minneapolis, MN, USA), and redo cardiac surgery for the
conduit replacement still represents a challenging proce-
dure. Minimal invasive off-pump trans-catheter techniques
for pulmonary stent-valve implantation carry a lower
operative risk and represent, nowadays, a clinical reality
in several cardiac centers [1—4]. Traditionally, stent-valve
positioning and implantation are based on intra-operative
angiographic images requiring several contrast injections,
and the stent valve is introduced through a transfemoral
venous access. Nevertheless, we have demonstrated that the
subxyphoidian approach for pulmonary trans-catheter valve
implantation is a safe and feasible alternative [5], and we
have also demonstrated that the angiography is no longer
necessary during trans-catheter procedures [6]. Following
our experience regarding endovascular aortic stent-graft
implantations without angiographies [7], we are routinely
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post-implantation control [8].
2. Procedural details
Preoperatively, all patients undergo cardiac computed
tomography (CT) scans and heart catheterizations (Fig. 1(A))
with low doses of contrast medium. Then, with a patient
under general anesthesia and in the operative theater, we
proceed as follows: our surgical access of choice is
subxyphoidian and the scar of the previous intervention
(median sternotomy) is extended for approximately 5—8 cm
under the xyphoid apophysis. Then, the diaphragmatic face
of the right ventricle is carefully exposed and pacemaker
wires are fixed and tested for rapid pacing. A double 3/0 or 2/
0 polypropylene purse-string suture reinforced with pledgets
(Teflon felts, 1  0.5 cm) is prepared where coronary arteries
are not visible. After heparinization (100 UI kg1), a guide
wire and an 11-F sheet are introduced into the right ventricle
toward the pulmonary trunk (straightforward). Then, the soft
guide wire is passed through the stenosed pulmonary valve
conduit and placed in the right pulmonary artery under
fluoroscopic guidance. An IVUS probe (9F, AcusonTM by
Siemens) is guided, over-the-wire, into the right ventricle
and across the stenosed pulmonary valve: using the pullback
technique, the pulmonary bifurcation, the pulmonary artery
(Fig. 1(B)), the distal end (Fig. 1(C)), and the proximal endurgery. Published by Elsevier B.V. All rights reserved.
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Fig. 2. (A) Measurements of the stenotic pulmonary valve conduit by IVUS; (B)
fluoroscopic imaging showing the IVUS probe and the metal markers for the
distal and the proximal end of the diseased pulmonary valve conduit; (C) the
stent-valve (Edwards SapienTM THV, Edwards Lifesciences, Irvine, CA, USA)
positioning under fluoroscopy using the metal markers as landmarks; and (D)
IVUS final control after the stent-valve implantation.
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Fig. 1. (A) Preoperative CT-scan showing the severely stenosed pulmonary valve
conduit; (B) IVUS imaging of the pulmonary artery; (C) IVUS imaging of the distal
end of the stenotic pulmonary valve conduit; and (D) IVUS imaging of the
proximal end of the stenotic pulmonary valve conduit.
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easily identified andmeasured with IVUS (Fig. 2(A)), and then
marked, under fluoroscopy, with metal markers placed in the
operative field (Fig. 2(B)), as already reported for the
endovascular aorta repair technique [7]. From this moment,
it becomes necessary to fix the fluoroscopy system in its final
position (we routinely use an high-quality portable C-arm
fluoroscopy by Philips, Eindhoven, the Netherlands) to avoid
tactless movements after the markers’ fixation. Thus, the
IVUS is pulled out, the soft guide wire is replaced by a super-
stiff guide wire, and the 11-F sheet is replaced by the
Edwards AscendraTM system (26F) for the valvuloplasty and
for the SapienTM valve implantation (Edwards Lifesciences,
Irvine, CA, USA). The fluoroscopy is required for the
positioning of the balloon catheters in the ideal landing
zone, in between the metal markers identifying the
beginning and the end of the stenotic portion (Fig. 2(C)),
and for the control of the balloon inflation during the
valvuloplasty and the valve deployment. We usually do not
implant vascular stents before the SapienTM implantation.
After the pulmonary valvuloplasty and the stent-valve
deployment under rapid cardiac pacing, the IVUS probe is
inserted again through the prosthesis to verify the circularity
of the deployed stent valve, the leaflets’ motion, and the
presence of residual stenosis requiring further dilatations
(Fig. 2(D)). Then, the IVUS probe, the guide wire, and the
sheet are pulled out, and the purse-string sutures are tied.
Usually, the entire procedure is performed without
contrast injections, and the results we collected so far (five
cases) are excellent with transesophageal echocardiographic
hemodynamic findings confirming low gradients and absence
of leaks. Moreover, the total fluoroscopy time is not longer
than a comparable procedure performed with repeated
angiographies.3. Conclusion
Less invasiveness in cardiac surgery is an emerging and
attractive concept that increasingly involves the valvular
field. In particular, the trans-catheter heart valve replace-
ment is a promising procedure with a lower operative risk,
and a special indication for patients requiring redo open-
heart surgery. However, less invasivity can also mean less
medications, less radiation doses, or less contrast mediuminjected intra-operatively for the cardiac imaging (to
prevent postoperative acute kidney insufficiency).
Following this principle, we have explored alternative
tools (IVUS) for cardiac imaging during trans-catheter
pulmonary stent-valve implantations: in our limited clinical
experience, the IVUS represents a useful tool allowing the
identification of the ideal landing zone in the diseased
pulmonary valve conduit, and the measurement of dia-
meters. Moreover, the postoperative IVUS control, coupled
with transesophageal echocardiography and fluoroscopy
without angiography, identifies residual stenosis, unex-
panded stent valves and leaks. The IVUS can be easily
performed, by an experienced team, both through a trans-
venous femoral access and through a subxyphoidian surgical
access, which is a valid alternative in case of inaccessibility
to the iliac/femoral vein axes or presence of cava filters. In
conclusion, the subxyphoidian trans-catheter pulmonary
stent-valve implantation is a full intrapericardial minimally
invasive valve procedure and, using the IVUS-guided SapienTM
THV implantation, can be performed without contrast
injections.
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